Literature DB >> 2928807

A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia.

P H Wiernik1, D C Case, P O Periman, Z A Arlin, A B Weitberg, P S Ritch, M B Todd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2928807

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  8 in total

Review 1.  Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Authors:  L M Hollingshead; D Faulds
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

Review 2.  Idarubicin: a pharmacoeconomic evaluation of its use in adult patients with acute myeloid leukaemia.

Authors:  R Whittington; K L Goa
Journal:  Pharmacoeconomics       Date:  1993-10       Impact factor: 4.981

3.  Southwestern Oncology Group pretreatment risk criteria as predictive or prognostic factors in acute myeloid leukemia.

Authors:  Ana Espirito Santo; Sergio Chacim; Isabel Ferreira; Luis Leite; Claudia Moreira; Dulcineia Pereira; Margarida Dantas; Marta Nunes; Luisa Viterbo; Ilidia Moreira; Angelo Martins; Isabel Oliveira; Nelson Domingues; Jose Mariz; Rui Medeiros
Journal:  Mol Clin Oncol       Date:  2017-01-20

Review 4.  Acute myeloid leukemia in the elderly: biological features and search for adequate treatment.

Authors:  V Heinemann; U Jehn
Journal:  Ann Hematol       Date:  1991-10       Impact factor: 3.673

5.  Acute myeloblastic leukaemia--a model for assessing value for money for new treatment programmes.

Authors:  P J Lobo; R L Powles; A Hanrahan; D K Reynold
Journal:  BMJ       Date:  1991-02-09

6.  Colonization with multidrug resistant organisms determines the clinical course of patients with acute myeloid leukemia undergoing intensive induction chemotherapy.

Authors:  Olivier Ballo; Ikram Tarazzit; Jan Stratmann; Claudia Reinheimer; Michael Hogardt; Thomas A Wichelhaus; Volkhard Kempf; Hubert Serve; Fabian Finkelmeier; Christian Brandts
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

7.  Acute kidney injury adversely affects the clinical course of acute myeloid leukemia patients undergoing induction chemotherapy.

Authors:  Olivier Ballo; Fagr Eladly; Stefan Büttner; Jan Alexander Stratmann; Sarah Rudolf; Uta Brunnberg; Eva-Maria Kreisel; Björn Steffen; Sebastian Wagner; Fabian Finkelmeier; Hubert Serve; Christian H Brandts
Journal:  Ann Hematol       Date:  2021-03-11       Impact factor: 3.673

8.  Fluid overload is associated with increased 90-day mortality in AML patients undergoing induction chemotherapy.

Authors:  Olivier Ballo; Fagr Eladly; Sebastian Koschade; Stefan Büttner; Jan Alexander Stratmann; Uta Brunnberg; Eva-Maria Kreisel; Franziska Frank; Sebastian Wagner; Björn Steffen; Hubert Serve; Fabian Finkelmeier; Christian H Brandts
Journal:  Ann Hematol       Date:  2021-07-25       Impact factor: 3.673
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.